Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer
Prostate Cancer
About this trial
This is an interventional supportive care trial for Prostate Cancer focused on measuring decision aid, focus group
Eligibility Criteria
Inclusion Criteria:
- Subjects utilize English or Spanish as their primary spoken or written language and identify with a Latino ethnicity and/or culture
- Men with a new histologic diagnosis of localized prostate cancer
- PSA level of 0.1 - 50 ng/dl
- Gleason score of 6 - 10
- Cancer stage: T1 - 4N x M0
Exclusion Criteria:
- Metastatic disease, including lymph nodes or distant metastasis
- PSA > 50 ng/dl
- Individuals with a medical condition that necessitates a specific prostate cancer treatment plan
- Individuals that are unwilling or unable to attend study visits or are planning to move out of a study site coverage area during the subject's anticipated participation in the study
Sites / Locations
Arms of the Study
Arm 1
Experimental
Decision Aid
Subjects will be asked to complete baseline surveys. Once the surveys are completed, subjects will review the Decision Aid tool with a study team member. Once the subjects have gone through the tool, study team members will answer any additional questions he may have regarding the tool. The subjects will then discuss with the investigator various cancer management options, quality of life implications, and any questions the subjects may have regarding cancer management options. Subjects that are ready may make a cancer management decision at this time, or choose to wait until their next scheduled visit. Subjects will be followed at subsequent urology clinic visits for up to 6 months. Subjects will complete follow-up surveys at the 3, 6, 9 and 12 month visits.